Oxford biotech secures $47 million to scale cell-based mRNA manufacturing, with an eye on therapies that require repeated dosing.
#longevity# #biotech# #mRNA# #manufacturing# #therapies#
Oxford Street has long been the nation’s high street.
On Monday 26 October, it’ll go permanently traffic-free and pave the way for a greener, more welcoming street with new opportunities for retail and leisure.
Oxford University scientists are developing a Bundibugyo Ebola vaccine, aiming for clinical trials within two to three months as Congo faces a deadly outbreak